Conditioned Medium
Phase 2Cell therapy
Conditioned Medium is one of 59 biologic programs targeting Cerebral Palsy. It is currently in Phase 2.
2
Indications
5
Total Trials
3
Active Trials
58
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
150 competitors in Stroke
#DrugCompanyPhaseTrials
1Zometa
PfizerPreclinical
Savella
AbbViePreclinical
Proamatine
TakedaPreclinical
Repatha
AmgenPreclinical
Conditioned Medium
PPT. Prodia Stem Cell Indonesia
Phase 2
Periactin
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Preclinical
Zantac 150
CChattem
Preclinical
Alka-Seltzer
AAbbott
Preclinical
Haldol
DDePuy Orthopaedics
Preclinical
Inderal
Mylan Pharmaceuticals IncPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Retinitis Pigmentosa2 trials
Keloid1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Conditioned Medium. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Cell therapy[2]
- Highest Phase
- Phase 2[1]
- Company
- PPT. Prodia Stem Cell Indonesia